Nifty
:
25868.60
Sensex
:
84426.34
25.45 (0.10%)
62.97 (0.07%)
Nifty
Sensex
:
:
25868.60
84426.34
25.45 (0.10%)
62.97 (0.07%)

Lincoln Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :
50/99

BSE: 531633 | NSE: LINCOLN

NSE BSE
527.50
21-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  523.4
  •  543.95
  •  521.4
  •  523.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6855
  •  3620841.25
  •  979.5
  •  499

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,056.47
  • 12.23
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,034.04
  • 0.34%
  • 1.51

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.78%
  • 1.31%
  • 36.26%
  • FII
  • DII
  • Others
  • 4.73%
  • 0.00%
  • 7.92%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.53
  • 8.00
  • 6.89

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.61
  • 3.09
  • 2.62

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.27
  • 5.76
  • 4.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.54
  • 11.25
  • 13.13

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.67
  • 1.74
  • 1.89

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.31
  • 7.62
  • 8.59

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
154.07
147.28
4.61%
168.18
142.49
18.03%
146.55
146.45
0.07%
161.21
155.99
3.35%
Expenses
130.26
124.55
4.58%
141.46
124.11
13.98%
122.89
116.79
5.22%
132.83
124.84
6.40%
EBITDA
23.81
22.73
4.75%
26.72
18.38
45.38%
23.66
29.66
-20.23%
28.38
31.15
-8.89%
EBIDTM
15.45%
15.43%
15.89%
12.90%
16.15%
20.25%
17.60%
19.97%
Other Income
15.27
10.41
46.69%
-6.88
7.02
-
8.97
11.02
-18.60%
9.98
8.70
14.71%
Interest
0.21
0.44
-52.27%
0.37
0.50
-26.00%
0.73
0.16
356.25%
0.35
0.39
-10.26%
Depreciation
3.48
3.22
8.07%
3.23
2.69
20.07%
3.22
2.81
14.59%
3.22
2.58
24.81%
PBT
35.39
29.48
20.05%
16.25
22.22
-26.87%
28.68
37.71
-23.95%
34.78
36.87
-5.67%
Tax
7.71
5.81
32.70%
4.67
3.62
29.01%
7.91
9.67
-18.20%
8.45
9.21
-8.25%
PAT
27.68
23.67
16.94%
11.57
18.60
-37.80%
20.77
28.04
-25.93%
26.33
27.65
-4.77%
PATM
17.96%
16.07%
6.88%
13.05%
14.17%
19.15%
16.33%
17.73%
EPS
13.82
11.82
16.92%
5.78
9.28
-37.72%
10.37
14.00
-25.93%
13.15
13.81
-4.78%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
630.01
623.23
580.55
510.31
472.12
424.19
386.49
366.15
360.61
360.26
400.15
Net Sales Growth
6.38%
7.35%
13.76%
8.09%
11.30%
9.75%
5.56%
1.54%
0.10%
-9.97%
 
Cost Of Goods Sold
290.46
202.66
204.07
179.43
169.71
155.86
138.15
135.66
156.44
202.90
254.64
Gross Profit
339.55
420.57
376.48
330.88
302.41
268.32
248.34
230.49
204.18
157.35
145.50
GP Margin
53.90%
67.48%
64.85%
64.84%
64.05%
63.25%
64.26%
62.95%
56.62%
43.68%
36.36%
Total Expenditure
527.44
521.74
480.64
421.11
376.64
337.01
320.95
298.91
308.30
313.52
359.62
Power & Fuel Cost
-
11.66
11.47
10.25
8.33
7.10
8.18
7.21
6.82
5.92
5.68
% Of Sales
-
1.87%
1.98%
2.01%
1.76%
1.67%
2.12%
1.97%
1.89%
1.64%
1.42%
Employee Cost
-
112.45
102.90
93.16
79.72
63.26
58.65
51.90
51.15
37.59
28.83
% Of Sales
-
18.04%
17.72%
18.26%
16.89%
14.91%
15.18%
14.17%
14.18%
10.43%
7.20%
Manufacturing Exp.
-
121.54
102.35
85.72
69.33
61.54
64.05
60.71
51.73
29.44
35.81
% Of Sales
-
19.50%
17.63%
16.80%
14.68%
14.51%
16.57%
16.58%
14.35%
8.17%
8.95%
General & Admin Exp.
-
39.46
29.91
31.06
27.56
23.06
21.30
20.98
17.50
14.78
20.34
% Of Sales
-
6.33%
5.15%
6.09%
5.84%
5.44%
5.51%
5.73%
4.85%
4.10%
5.08%
Selling & Distn. Exp.
-
30.87
26.71
19.20
19.49
24.54
26.79
20.02
21.24
19.91
10.10
% Of Sales
-
4.95%
4.60%
3.76%
4.13%
5.79%
6.93%
5.47%
5.89%
5.53%
2.52%
Miscellaneous Exp.
-
3.10
3.23
2.28
2.51
1.64
3.83
2.43
3.44
2.97
10.10
% Of Sales
-
0.50%
0.56%
0.45%
0.53%
0.39%
0.99%
0.66%
0.95%
0.82%
1.05%
EBITDA
102.57
101.49
99.91
89.20
95.48
87.18
65.54
67.24
52.31
46.74
40.53
EBITDA Margin
16.28%
16.28%
17.21%
17.48%
20.22%
20.55%
16.96%
18.36%
14.51%
12.97%
10.13%
Other Income
27.34
22.48
34.42
22.47
10.00
5.66
11.04
5.63
5.45
2.78
7.36
Interest
1.66
1.88
1.46
2.03
1.45
1.56
2.02
4.00
5.41
6.66
9.96
Depreciation
13.15
12.90
10.62
9.17
8.09
7.56
7.33
6.68
6.11
5.51
4.87
PBT
115.10
109.19
122.24
100.48
95.94
83.72
67.23
62.19
46.25
37.33
33.07
Tax
28.74
26.84
28.94
27.58
26.58
21.47
15.77
13.46
11.60
9.20
9.27
Tax Rate
24.97%
24.58%
23.67%
27.45%
27.70%
25.65%
23.46%
21.64%
25.08%
24.65%
28.03%
PAT
86.35
82.35
93.30
72.90
69.36
62.25
51.44
48.71
34.62
28.12
23.68
PAT before Minority Interest
86.35
82.35
93.30
72.90
69.36
62.25
51.47
48.74
34.65
28.13
23.80
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.01
-0.12
PAT Margin
13.71%
13.21%
16.07%
14.29%
14.69%
14.68%
13.31%
13.30%
9.60%
7.81%
5.92%
PAT Growth
-11.85%
-11.74%
27.98%
5.10%
11.42%
21.01%
5.60%
40.70%
23.12%
18.75%
 
EPS
43.18
41.18
46.65
36.45
34.68
31.13
25.72
24.36
17.31
14.06
11.84

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
671.67
592.84
502.47
432.88
366.39
313.09
269.34
224.22
192.38
140.52
Share Capital
20.03
20.03
20.03
20.03
20.03
20.00
20.00
20.00
20.00
16.31
Total Reserves
651.64
572.81
482.44
412.85
346.36
293.09
249.34
204.22
172.38
116.65
Non-Current Liabilities
19.12
15.18
38.02
10.99
26.10
42.85
28.43
24.94
31.75
33.74
Secured Loans
0.00
0.00
0.00
0.00
0.14
0.85
1.69
6.93
12.38
23.62
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.73
0.10
25.36
0.00
15.98
32.51
17.49
7.19
9.98
0.00
Current Liabilities
131.09
117.41
96.01
110.71
94.78
80.32
100.37
113.48
99.42
100.34
Trade Payables
84.95
72.44
50.87
71.67
57.07
51.24
44.01
43.42
32.46
30.38
Other Current Liabilities
14.78
15.18
14.51
9.84
13.43
9.13
11.11
11.11
12.77
15.10
Short Term Borrowings
0.00
1.07
2.00
2.04
0.00
3.83
30.09
48.55
45.04
52.62
Short Term Provisions
31.36
28.73
28.64
27.16
24.28
16.11
15.16
10.41
9.15
2.24
Total Liabilities
821.88
725.43
636.50
554.58
487.27
436.64
398.50
362.97
323.85
274.79
Net Block
181.97
179.33
150.53
131.88
110.64
122.72
120.91
116.58
102.71
98.47
Gross Block
251.98
236.65
197.47
171.07
141.90
146.70
138.11
127.65
108.16
120.89
Accumulated Depreciation
70.01
57.32
46.95
39.19
31.26
23.98
17.21
11.08
5.45
22.42
Non Current Assets
297.07
262.51
245.42
181.51
159.59
173.91
159.43
136.08
134.27
127.83
Capital Work in Progress
4.47
3.48
6.71
16.05
1.69
0.04
2.10
0.29
6.63
2.73
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.09
0.09
0.09
0.09
0.01
Long Term Loans & Adv.
110.63
79.70
88.18
31.83
46.81
51.02
36.01
18.79
24.48
26.62
Other Non Current Assets
0.00
0.00
0.00
1.75
0.45
0.03
0.33
0.34
0.36
0.00
Current Assets
524.81
462.91
391.08
373.07
327.69
262.73
239.08
226.88
189.58
146.98
Current Investments
173.72
138.92
91.33
96.81
80.66
34.22
18.07
10.97
10.25
0.00
Inventories
78.68
77.17
70.03
72.74
46.61
47.40
36.23
45.41
37.31
27.48
Sundry Debtors
166.40
161.77
136.33
115.94
113.35
101.34
122.47
109.44
90.67
80.53
Cash & Bank
22.43
13.83
34.32
18.80
13.84
14.58
7.58
14.59
11.68
12.66
Other Current Assets
83.59
1.69
2.10
1.19
73.22
65.20
54.74
46.47
39.68
26.31
Short Term Loans & Adv.
80.95
69.54
56.98
67.59
71.79
64.09
53.64
45.18
39.02
26.26
Net Current Assets
393.72
345.50
295.07
262.36
232.91
182.41
138.71
113.40
90.16
46.63
Total Assets
821.88
725.42
636.50
554.58
487.28
436.64
398.51
362.96
323.85
274.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
93.02
63.22
39.26
76.13
69.27
75.42
52.84
26.63
25.04
44.80
PBT
109.19
122.24
100.48
95.94
83.72
67.23
62.19
46.25
37.33
33.07
Adjustment
0.96
-16.76
-0.23
1.48
4.84
8.66
9.30
11.64
10.70
13.75
Changes in Working Capital
9.17
-16.12
-31.37
2.40
0.20
14.33
-1.12
-22.00
-13.24
4.80
Cash after chg. in Working capital
119.32
89.37
68.87
99.83
88.76
90.22
70.38
35.88
34.79
51.62
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-26.31
-26.15
-29.61
-23.70
-19.49
-14.81
-17.53
-9.25
-9.75
-6.82
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-78.95
-57.34
-36.64
-78.08
-64.23
-30.88
-18.19
-11.77
-25.48
-41.79
Net Fixed Assets
-16.32
-35.95
-17.06
-43.53
-35.54
-5.59
-11.52
-12.45
4.05
-29.04
Net Investments
-34.80
-47.59
5.48
-16.15
-20.70
-14.20
-7.10
-2.72
-16.01
-7.34
Others
-27.83
26.20
-25.06
-18.40
-7.99
-11.09
0.43
3.40
-13.52
-5.41
Cash from Financing Activity
-6.40
-5.18
-4.50
-2.56
-5.75
-37.76
-35.77
-11.41
0.30
-3.42
Net Cash Inflow / Outflow
7.67
0.70
-1.88
-4.50
-0.70
6.77
-1.11
3.45
-0.14
-0.41
Opening Cash & Equivalents
5.75
5.05
6.93
11.44
12.14
5.46
6.57
3.12
3.26
3.75
Closing Cash & Equivalent
13.41
5.75
5.05
6.93
11.44
12.23
5.46
6.57
3.12
3.43

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
335.34
295.98
250.86
216.12
182.92
156.54
134.67
112.11
96.19
81.52
ROA
10.64%
13.70%
12.24%
13.31%
13.48%
12.33%
12.80%
10.09%
9.40%
8.87%
ROE
13.02%
17.04%
15.59%
17.35%
18.32%
17.67%
19.75%
16.63%
17.29%
19.49%
ROCE
17.55%
22.53%
21.82%
24.29%
24.90%
22.30%
22.50%
19.05%
18.51%
21.18%
Fixed Asset Turnover
2.67
2.80
2.90
3.17
3.04
2.81
2.84
3.07
3.19
3.90
Receivable days
91.75
89.63
86.09
84.27
89.34
102.22
112.23
100.99
85.52
89.69
Inventory Days
43.57
44.26
48.72
43.86
39.12
38.19
39.51
41.74
32.36
22.16
Payable days
141.73
110.27
124.63
138.44
126.82
56.60
57.26
47.62
37.21
40.22
Cash Conversion Cycle
-6.41
23.61
10.19
-10.30
1.64
83.82
94.48
95.11
80.67
71.63
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.02
0.12
0.27
0.34
0.59
Interest Cover
58.99
84.45
50.49
67.11
54.61
34.32
16.56
9.55
6.60
4.32

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Lincoln Pharma - Quarterly Results
    7th Aug 2025, 12:55 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.